Funder
the Key Technologies Research and Development Program
National Institute of Health
National Nature Science Foundation of China
CRDF Global
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Grinsztejn B, Hosseinipour MC, Ribaudo HJ, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014;14(4):281–90. https://doi.org/10.1016/s1473-3099(13)70692-3.
2. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505. https://doi.org/10.1056/NEJMoa1105243.
3. The Joint United Nations Program on HIV/AIDS. Global HIV & AIDS statistics 2021. https://www.unaids.org/en/resources/fact-sheet. Accessed 30 Nov 2023.
4. Hu X, Zhao Y, Huang L, Luo Y, Wu Z. Antiretroviral treatment discontinuation and its influencing factors among HIV-infected patients who initiated ART from 2012 to 2015 in Wenshan prefecture, Yunnan Province. Zhonghua Yu Fang Yi Xue Za Zhi. 2017;51(11):982–7. https://doi.org/10.3760/cma.j.issn.0253-9624.2017.11.006.
5. Centres for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data United States and 6 dependent areas, 2020. 2021. https://www.cdc.gov/hiv/library/reports/hiv-surveillance/vol-27-no-3/index.html. Accessed 30 Nov 2023.